Ticker
DNACompany Name
GINKGO BIOWORKS HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -273.71M | -118.59% | $ 230.81M |
3/31/2025 | $ -344.65M | -145.17% | $ 237.42M |
12/31/2024 | $ -381.48M | -168.02% | $ 227.04M |
9/30/2024 | $ -385.24M | -176.75% | $ 217.95M |
6/30/2024 | $ -344.91M | -187.11% | $ 184.34M |
3/31/2024 | $ -318.43M | -152.58% | $ 208.7M |
12/31/2023 | $ -331.87M | -131.98% | $ 251.46M |
9/30/2023 | $ -402.37M | -127.74% | $ 314.99M |
6/30/2023 | $ -366.29M | -112.37% | $ 325.95M |
3/31/2023 | $ -390.4M | -100.1% | $ 390M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for GINKGO BIOWORKS HOLDINGS INC is calculated as follows: FCF [ $ -139.68M ] / Revenues [ $ 165.34M ]
(=) FCF % [ -84.48% ]
Minimum
Jun 30, 2024
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.86% |
median | 7.37% |
std | 19.48% |